France Biotechnology & Medical Research

Novacyt SA (ALNOV)

Track

Track

Novacyt SA recorded multiple insider trading transactions on March 27, 2026, involving three PDMRs purchasing shares. These acquisitions represent the most recent activity for the firm. Historical data indicates a consistent pattern of buying by various executives and directors over several years, reflecting long-term participation by leadership within the company equity structure.
Ticker: ALNOV Exchange: PAR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Novacyt SA. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Ian Gilham See 1(a) - classified as a PDMR of the Company
Transaction date
Purchase
Price
261.10
Quantity 384
Value £1,215,558
John Brown See 1(a) - classified as a PDMR of the Company
Transaction date
Purchase
Price
486.50
Quantity 32,438
Value €141,215
Lyn Rees See 1(a) - classified as a PDMR of the Company
Transaction date
Purchase
Price
106.95
Quantity 68,556
Value €2,559,095
James Wakefield Chairman Director
Transaction date
Purchase
Price
1.17
Quantity 7,000
Value £8,190
David Allmond Chief Executive Officer Officer
Transaction date
Purchase
Price
2.31
Quantity 43,500
Value £100,485
Jean-Pierre Crinelli Non-Executive Director Executive Director
Transaction date
Purchase
Price
2.41
Quantity 3,208
Value €7,731
Jean-Pierre Crinelli PCA to Jean-Pierre Crinelli (PDMR)
Through Sylvie Dugat, a closely affiliated person
Transaction date
Purchase
Price
2.58
Quantity 5,800
Value €14,964
James McCarthy Chief Financial Officer Officer
Transaction date
Purchase
Price
2.02
Quantity 39,670
Value £80,133
Guillermo Raimondo Chief Commercial Officer Officer
Transaction date
Purchase
Price
3.85
Quantity 10,000
Value €38,500
James McCarthy Corporate consultant
Transaction date
Purchase
Price
8.95
Quantity 10,000
Value £89,530
Steve Gibson PCA to Steve Gibson (PDMR)
Through Anouska Penny-Gibson, a closely affiliated person
Transaction date
Purchase
Price
8.59
Quantity 697
Value £5,987
Jean-Pierre Crinelli Non-Executive Director Executive Director
Transaction date
Purchase
Price
9.70
Quantity 1,541
Value €14,948
Graham Mullis Chief Executive Officer Officer
Transaction date
Purchase
Price
8.17
Quantity 60,875
Value £497,349
Edwin Snape Non-Executive Director Executive Director
Transaction date
Purchase
Price
7.17
Quantity 1,080
Value £7,744
Dr Andrew Heath Non Executive Director Executive Director
Transaction date
Purchase
Price
3.05
Quantity 3,161
Value £9,641
Jean-Pierre Crinelli Non Executive Director Executive Director
Transaction date
Purchase
Price
3.38
Quantity 5,899
Value €19,927
James Wakefield Non-Executive Director & Chairman of the Board Executive Director
Transaction date
Purchase
Price
3.05
Quantity 20,000
Value £60,980
Graham Mullis Chief Executive Officer Officer
Transaction date
Purchase
Price
3.10
Quantity 9,493
Value £29,428
Jean-Pierre Crinelli Non-Executive Director Executive Director
Transaction date
Purchase
Price
1.27
Quantity 8,000
Value €10,192
3.3
jean-pierre crinelli administrateur Director
Through CUP92 SAS, a closely affiliated person
Transaction date
Sale
Price
0.67
Quantity 5,984
Value €4,009
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-30 2026-03-27 B Purchase Ian Gilham

See 1(a) - classified as a PDMR of the Company
384
261.10
£1,215,558 		384 261.10 £1,215,558
2026-03-30 2026-03-27 B Purchase John Brown

See 1(a) - classified as a PDMR of the Company
32,438
486.50
€141,215 		32,438 486.50 €141,215
2026-03-30 2026-03-27 B Purchase Lyn Rees

See 1(a) - classified as a PDMR of the Company
68,556
106.95
€2,559,095 		68,556 106.95 €2,559,095
2022-07-07 2022-07-07 B Purchase James Wakefield

Chairman

Director
7,000
1.17
£8,190 		7,000 1.17 £8,190
2022-03-25 2022-03-25 B Purchase David Allmond

Chief Executive Officer

Officer
43,500
2.31
£100,485 		43,500 2.31 £100,485
2022-03-18 2022-03-18 B Purchase Jean-Pierre Crinelli

Non-Executive Director

Executive Director
3,208
2.41
€7,731 		3,208 2.41 €7,731
2022-03-18 2022-03-15 B Purchase Jean-Pierre Crinelli

PCA to Jean-Pierre Crinelli (PDMR)

Through Sylvie Dugat, a closely affiliated person
5,800
2.58
€14,964 		5,800 2.58 €14,964
2022-03-15 2022-03-14 B Purchase James McCarthy

Chief Financial Officer

Officer
39,670
2.02
£80,133 		39,670 2.02 £80,133
2021-07-06 2021-07-05 B Purchase Guillermo Raimondo

Chief Commercial Officer

Officer
10,000
3.85
€38,500 		10,000 3.85 €38,500
2020-11-13 2020-11-13 B Purchase James McCarthy

Corporate consultant
10,000
8.95
£89,530 		10,000 8.95 £89,530
2020-11-18 2020-11-12 B Purchase Steve Gibson

PCA to Steve Gibson (PDMR)

Through Anouska Penny-Gibson, a closely affiliated person
697
8.59
£5,987 		697 8.59 £5,987
2020-11-13 2020-11-12 B Purchase Jean-Pierre Crinelli

Non-Executive Director

Executive Director
1,541
9.70
€14,948 		1,541 9.70 €14,948
2020-11-12 2020-11-11 B Purchase Graham Mullis

Chief Executive Officer

Officer
60,875
8.17
£497,349 		60,875 8.17 £497,349
2020-11-11 2020-11-10 B Purchase Edwin Snape

Non-Executive Director

Executive Director
1,080
7.17
£7,744 		1,080 7.17 £7,744
2020-06-03 2020-06-03 B Purchase Dr Andrew Heath

Non Executive Director

Executive Director
3,161
3.05
£9,641 		3,161 3.05 £9,641
2020-05-26 2020-05-25 B Purchase Jean-Pierre Crinelli

Non Executive Director

Executive Director
5,899
3.38
€19,927 		5,899 3.38 €19,927
2020-05-18 2020-05-15 B Purchase James Wakefield

Non-Executive Director & Chairman of the Board

Executive Director
20,000
3.05
£60,980 		20,000 3.05 £60,980
2020-05-18 2020-05-15 B Purchase Graham Mullis

Chief Executive Officer

Officer
9,493
3.10
£29,428 		9,493 3.10 £29,428
2020-11-13 2020-03-20 B Purchase Jean-Pierre Crinelli

Non-Executive Director

Executive Director
8,000
1.27
€10,192 		8,000 1.27 €10,192
2017-10-30 2017-10-27 S Sale
3.3
jean-pierre crinelli

administrateur

Through CUP92 SAS, a closely affiliated person Director
5,984
0.67
€4,009 		5,984 0.67 €4,009
Explore more

More insider trading research around Novacyt SA

More insider trades in France
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe